Multiparameter immunophenotyping by flow cytometry as a diagnostic tool in multiple myeloma and monoclonal gammopathy of undetermined significance

Clinica Terapeutica

Volumn 163, Issue 5, 2012, Pages 387-392

  Carulli, G ^a   Ottaviano, V ^a   Cannizzo, E ^a   Giuntini, S ^a   Manetti, C ^a   Ciancia, E M ^b   Azzara A ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

Immunophenotyping; Monoclonal gammopathy of undetermined significance; Multiparameter flow cytometry; Multiple myeloma

Indexed keywords

CD19 ANTIBODY; CD20 ANTIBODY; CD27 ANTIGEN; CD28 ANTIGEN; CD56 ANTIGEN; STEM CELL FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CELL POPULATION; CONTROLLED STUDY; DIAGNOSTIC ERROR; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DOUBLE BLIND PROCEDURE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PLASMA CELL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; DOUBLE-BLIND METHOD; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE; MULTIPLE MYELOMA;

EID: 84872476447     PISSN: 00099074     EISSN: 19726007     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Rawstron AC, Orfao A, Beksac M, et al. Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders. Haematologica 200; 93:431-8
2. Bataille R, Jégo G, Robillard N, et al. The phenotype of normal, reactive and malignant plasma cells. Identification of "many and multiple myelomas" and of new targets for myeloma therapy. Haematologica 2006; 91:1234-40
3. Paiva B, Vidriales M-B, Pérez JJ, et al. Multiparameter flow cytometry quantification of bone marrow plasma cells at diagnosis provides more prognostic information than morphological assessment in myeloma patients. Haematologica 2009; 94:1599-602
4. Mateo G, Montalbán MA, Vidriales M-B, et al. Prognostic value of immunophenotyping in multiple myeloma: a study by the PETHEMA/GEM cooperative study groups on patients uniformly treated with high-dose therapy. J Clin Oncol 2008; 26:2737-44
5. Owen RG, Rawstron AC. Minimal residual disease monitoring in multiple myeloma: flow cytometry is the method of choice. Br J Haematol 2005; 128:732-3
6. Lioznov M, Badbaran A, Fehse B, et al. Monitoring of minimal residual disease in multiple myeloma after allo-SCT: flow cytometry vs PCR-based techniques. Bone Marrow Transplant 2008; 41:913-6
7. Ocquetau M, Orfao A, Almeida J, et al. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the Differential Diagnosis between MGUS and Multiple Myeloma. Am J Pathol 1998; 152:1655-65
8. Perez-Persona E, Viadriales M-B, Mateo G, et al. New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells. Blood 2007; 110:2586-92
9. San Miguel JF, Gutiérrez NC, Mateo G, et al. Conventional diagnostics in multiple myeloma. Eur J Cancer 2006; 42: 1510-9
10. Olteanu H, Wang H-Y, Chen W, et al. Immunophenotypic studies of monoclonal gammopathy of undetermined significance. BMC Clin Pathol 2008; 8:13
11. International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 2003; 121:749-57
12. Kyle RA, Rajkumar SV. Criteria for diagnosis, staging, risk stratification and response assessment of multiple Myeloma. Leukemia 2009; 23:3-9
13. Carulli G, Cannizzo E, Ottaviano V, et al. Abnormal phenotype of bone marrow plasma cells in patients with chronic myeloid leukemia undergoing therapy with Imatinib. Leukemia Res 2010; 34:1336-9
14. Lin P, Owens R, Tricot G, et al. Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma. Am J Clin Pathol 2004; 121:482-8
15. Kovarova L, Buresova I, Buchler T, et al. Phenotype of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significante. Neoplasma 2009; 56:526-32
16. Gupta R, Bhaskar A, Kumar L, et al. Flow cytometric immunophenotyping and minimal residual disease analysis in multiple myeloma. Am J Clin Pathol 2009; 132:728-32
17. Sezer O, Heider U, Zavrski I, et al. Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells. Haematologica 2011; 86:837-43
18. Nadav L, Katz B-Z, Baron S, et al. Diverse niches within multiple myeloma bone marrow aspirates affect plasma cell enumeration. Br J Haematol 2007; 133:530-2
19. th ed. 2010; 421-60
20. Cannizzo E, Bellio E, Sohani AR, et al. Multiparameter immunophenotyping by flow cytometry in multiple myeloma: the diagnostic utility of defining ranges of normal antigenic expression in comparison to histology. Cytometry Part B 2010; 78B:231-8